These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2949160)

  • 21. [Clinical experiences with prostaglandin E1 in severe peripheral artery disease].
    Carlson LA; Jogestrand T; Kaijser L; Olsson AG
    Lakartidningen; 1977 Aug; 74(31):2629-33. PubMed ID: 895269
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparison of 2 effective doses of Fludilat in peripheral vascular disorders in a double-blind trial].
    König FK
    Med Welt; 1973 Sep; 24(39):1490-2. PubMed ID: 4588974
    [No Abstract]   [Full Text] [Related]  

  • 23. [Behavior of blood pressure and peripheral hemodynamics in interval therapy in untreated and propranolol-treated patients with arterial circulatory disorders of the lower extremities].
    Winterfeld HJ; Strangfeld D; Siewert H; Schmidt HH; Mederacke W
    Z Gesamte Inn Med; 1984 Sep; 39(18):447-50. PubMed ID: 6506819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and hemodynamic evaluation of the action of pentoxifylline in patients with obstructive arteriopathy of the lower extremities].
    Zaccaria A; Antonini M; Marciani A; Taurino M; Speziale F; Spartera C
    Ric Clin Lab; 1981; 11 Suppl 1():381-6. PubMed ID: 7188126
    [No Abstract]   [Full Text] [Related]  

  • 25. [Istrumental evaluation of the effects of a delayed-action preparation of isoxsuprine on the peripheral circulation].
    Iarussi D; Ferrante MR; Garofalo S; De Cristofaro M
    Clin Ter; 1977 Feb; 80(4):315-25. PubMed ID: 852237
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experiences with ultra-high dosage fibrinolysis in arterial occlusive disease].
    Redecker M; Heinrich F; Fenn K
    Vasa Suppl; 1988; 23():182-5. PubMed ID: 3206334
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of the efficacy of medical treatment, especially anticoagulant treatment, in arteriopathies of the lower limbs. Apropos of 41 cases].
    Chérif T; Kallel N; Guediche M
    Tunis Med; 1986 May; 64(5):475-80. PubMed ID: 3824555
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment with piribedil in peripheral arterial diseases].
    Gatta L; Corti G; Bernasconi S
    Minerva Med; 1976 May; 67(25):1668-70. PubMed ID: 778669
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical effect of high doses of o-betahydroxyethyl-rutosides in patients with occlusive arterial disease.
    Bielawiec M; Lukjan H; Kiersnowska-Rogowska B; Dabrowski S
    Bibl Anat; 1979; (18):378-81. PubMed ID: 496871
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical and instrumental evaluation of patients with chronic peripheral arterial occlusive disease after prolonged administration of suloctidil].
    Gregoratti L; Redaelli G; Limido P; Ghiringhelli L
    Clin Ter; 1982 Sep; 102(6):607-19. PubMed ID: 6291844
    [No Abstract]   [Full Text] [Related]  

  • 31. [Intra-arterial vasodilatative infusion and normal blood supply in peripheral angiopathy].
    Bartusch M; Ridha G; Mörl H; Preuss EG
    Angiologica; 1973; 10(1):24-30. PubMed ID: 4710547
    [No Abstract]   [Full Text] [Related]  

  • 32. [Changes of lower leg blood circulation during oral therapy with naftidrofuryl (dusodril)].
    Kriessmann A; Rädler M
    Munch Med Wochenschr; 1973 Mar; 115(12):508-10. PubMed ID: 4739661
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effectiveness of ultraviolet irradiation of blood in patients with arterial occlusive disease].
    Richard F; Zabel-Langhennig R
    Z Arztl Fortbild (Jena); 1987; 81(17):889-92. PubMed ID: 3439206
    [No Abstract]   [Full Text] [Related]  

  • 34. [Adrevil improves the peripheral blood flow. Results of a study using the 133-Xe muscle clearance method on lower limbs].
    Klemm J
    Fortschr Med; 1977 Jul; 95(28):1791-4. PubMed ID: 410717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
    Frausini G; Rotatori P; Gaggi S; Barone A; Pupita F
    Minerva Cardioangiol; 1988 Jun; 36(6):319-22. PubMed ID: 3211330
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of nitrates on the peripheral arterial vascular system].
    Podhaisky H; Hänsgen K; Bartlitz C
    Z Gesamte Inn Med; 1987 Feb; 42(3):79-81. PubMed ID: 2954307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial.
    Dal Lago A; De Martini D; Flore R; Gaetani E; Gasbarrini A; Gerardino L; Pola R; Santoliquido A; Serricchio M; Tondi P; Nolfe G
    Drugs Exp Clin Res; 1999; 25(1):29-36. PubMed ID: 10337502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug therapy in peripheral arterial occlusive disease].
    Bollinger A
    Schweiz Med Wochenschr; 1988 Sep; 118(36):1283-9. PubMed ID: 3051339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of Prodectin (pyridinolcarbamate) treatment of the circulation rate in obliterating arterial diseases of the lower extremities.
    Fényes G; Gótzy G; Fehrentheil L
    Ther Hung; 1975; 23(2):64-66. PubMed ID: 1188705
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.